Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

8JBA

Discovery and Crystallography Study of Novel Oxadiazole Analogs as Small Molecule PD-1/PD-L1 inhibitors

Summary for 8JBA
Entry DOI10.2210/pdb8jba/pdb
DescriptorProgrammed cell death 1 ligand 1, (2~{S})-2-[[3-[[5-[(2-methyl-3-phenyl-phenoxy)methyl]-1,3,4-oxadiazol-2-yl]sulfanylmethyl]phenyl]methylamino]-3-oxidanyl-propanoic acid (3 entities in total)
Functional Keywordsimmune checkpoint, dimer, inhibitor, immune system
Biological sourceHomo sapiens (human)
Total number of polymer chains2
Total formula weight29863.10
Authors
Cheng, Y.,Xiao, Y.B. (deposition date: 2023-05-08, release date: 2023-10-25, Last modification date: 2024-10-23)
Primary citationLiu, J.,Cheng, Y.,Yuan, L.,Liu, T.,Ruan, Y.,Ren, Y.,Li, L.,Jiang, S.,Xiao, Y.,Chen, J.
Discovery and Crystallography Study of Novel Biphenyl Ether and Oxadiazole Thioether (Non-Arylmethylamine)-Based Small-Molecule PD-1/PD-L1 Inhibitors as Immunotherapeutic Agents.
J.Med.Chem., 66:13172-13188, 2023
Cited by
PubMed Abstract: Current small-molecule PD-1/PD-L1 inhibitors are mainly based on the arylmethylamine/biphenyl core scaffold. Herein, we designed for the first time a series of non-arylmethylamine analogues (oxadiazole thioether derivatives) as small-molecule PD-1/PD-L1 inhibitors. Among them, compound exhibited the most potent PD-L1 inhibitory activity with an IC of 16.7 nM, 3.2-fold better than the lead (IC = 53.6 nM). The X-ray crystal structure of in complex with PD-L1 was solved at a resolution of 2.6 Å, which further confirmed the high binding affinity of to PD-L1. In the HepG2/Jurkat T cell co-culture model, effectively promoted HepG2 cell death by restoring the immune function of T cells. In addition, showed excellent antitumor efficacy (TGI = 88.6% at 30 mg/kg) and benign toxicity profiles in a B16-F10 tumor model by modulating PD-L1. In summary, represents the first non-arylmethylamine-based small-molecule PD-1/PD-L1 inhibitor worthy of further investigation.
PubMed: 37674362
DOI: 10.1021/acs.jmedchem.3c01141
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.6 Å)
Structure validation

227561

PDB entries from 2024-11-20

PDB statisticsPDBj update infoContact PDBjnumon